1887

Journal of General Virology header logo

Volume 96, Issue 4

Silencing the shutoff protein of Epstein–Barr virus in productively infected B cells points to (innate) targets for immune evasion Free

Abstract

During productive infection with Epstein–Barr virus (EBV), a dramatic suppression of cellular protein expression is caused by the viral alkaline exonuclease BGLF5. Among the proteins downregulated by BGLF5 are multiple immune components. Here, we show that shutoff reduces expression of the innate EBV-sensing Toll-like receptor-2 and the lipid antigen-presenting CD1d molecule, thereby identifying these proteins as novel targets of BGLF5. To silence BGLF5 expression in B cells undergoing productive EBV infection, we employed an shRNA approach. Viral replication still occurred in these cells, albeit with reduced late gene expression. Surface levels of a group of proteins, including immunologically relevant molecules such as CD1d and HLA class I and class II, were only partly rescued by depletion of BGLF5, suggesting that additional viral gene products interfere with their expression. Our combined approach thus provides a means to unmask novel EBV (innate) immune evasion strategies that may operate in productively infected B cells.

  • Received:
  • Accepted:
  • Published Online:
© 2015 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000021
2015-04-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/4/858.html?itemId=/content/journal/jgv/10.1099/jgv.0.000021&mimeType=html&fmt=ahah

References

  1. Barnes P. D., Grundy J. E. 1992; Down-regulation of the class I HLA heterodimer and β2-microglobulin on the surface of cells infected with cytomegalovirus. J Gen Virol 73:2395–2403 [View Article][PubMed]
     [Google Scholar]
  2. Clyde K., Glaunsinger B. A. 2011; Deep sequencing reveals direct targets of gammaherpesvirus-induced mRNA decay and suggests that multiple mechanisms govern cellular transcript escape. PLoS ONE 6:e19655 [View Article][PubMed]
     [Google Scholar]
  3. Covarrubias S., Richner J. M., Clyde K., Lee Y. J., Glaunsinger B. A. 2009; Host shutoff is a conserved phenotype of gammaherpesvirus infection and is orchestrated exclusively from the cytoplasm. J Virol 83:9554–9566 [View Article][PubMed]
     [Google Scholar]
  4. Delecluse H. J., Feederle R., Behrends U., Mautner J. 2008; Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus. Semin Cancer Biol 18:409–415 [View Article][PubMed]
     [Google Scholar]
  5. El-Guindy A., Lopez-Giraldez F., Delecluse H. J., McKenzie J., Miller G. 2014; A locus encompassing the Epstein-Barr virus bglf4 kinase regulates expression of genes encoding viral structural proteins. PLoS Pathog 10:e1004307 [View Article][PubMed]
     [Google Scholar]
  6. Feederle R., Bannert H., Lips H., Müller-Lantzsch N., Delecluse H. J. 2009a; The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication. J Virol 83:4952–4962 [View Article][PubMed]
     [Google Scholar]
  7. Feederle R., Mehl-Lautscham A. M., Bannert H., Delecluse H. J. 2009b; The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production. J Virol 83:10877–10891 [View Article][PubMed]
     [Google Scholar]
  8. Feng P., Moses A., Früh K. 2013; Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses. Curr Opin Virol 3:285–295 [View Article][PubMed]
     [Google Scholar]
  9. Gaglia M. M., Covarrubias S., Wong W., Glaunsinger B. A. 2012; A common strategy for host RNA degradation by divergent viruses. J Virol 86:9527–9530 [View Article][PubMed]
     [Google Scholar]
  10. Gaudreault E., Fiola S., Olivier M., Gosselin J. 2007; Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J Virol 81:8016–8024 [View Article][PubMed]
     [Google Scholar]
  11. Glaunsinger B., Ganem D. 2004; Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol Cell 13:713–723 [View Article][PubMed]
     [Google Scholar]
  12. Griffin B. D., Verweij M. C., Wiertz E. J. H. J. 2010; Herpesviruses and immunity: the art of evasion. Vet Microbiol 143:89–100 [View Article][PubMed]
     [Google Scholar]
  13. Horst D., van Leeuwen D., Croft N. P., Garstka M. A., Hislop A. D., Kremmer E., Rickinson A. B., Wiertz E. J. H. J., Ressing M. E. 2009; Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation. J Immunol 182:2313–2324 [View Article][PubMed]
     [Google Scholar]
  14. Horst D., Geerdink R. J., Gram A. M., Stoppelenburg A. J., Ressing M. E. 2012a; Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation. Viruses 4:2379–2399 [View Article][PubMed]
     [Google Scholar]
  15. Horst D., Burmeister W. P., Boer I. G. J., van Leeuwen D., Buisson M., Gorbalenya A. E., Wiertz E. J. H. J., Ressing M. E. 2012b; The “bridge” in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection. J Virol 86:9175–9187 [View Article][PubMed]
     [Google Scholar]
  16. Iwakiri D., Zhou L., Samanta M., Matsumoto M., Ebihara T., Seya T., Imai S., Fujieda M., Kawa K., Takada K. 2009; Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J Exp Med 206:2091–2099 [View Article][PubMed]
     [Google Scholar]
  17. Iwasaki A., Medzhitov R. 2010; Regulation of adaptive immunity by the innate immune system. Science 327:291–295 [View Article][PubMed]
     [Google Scholar]
  18. Jones T. R., Hanson L. K., Sun L., Slater J. S., Stenberg R. M., Campbell A. E. 1995; Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol 69:4830–4841[PubMed]
     [Google Scholar]
  19. Kinjo Y., Kitano N., Kronenberg M. 2013; The role of invariant natural killer T cells in microbial immunity. J Infect Chemother 19:560–570 [View Article][PubMed]
     [Google Scholar]
  20. Koppers-Lalic D., Rychlowski M., van Leeuwen D., Rijsewijk F. A. M., Ressing M. E., Neefjes J. J., Bienkowska-Szewczyk K., Wiertz E. J. H. J. 2003; Bovine herpesvirus 1 interferes with TAP-dependent peptide transport and intracellular trafficking of MHC class I molecules in human cells. Arch Virol 148:2023–2037 [View Article][PubMed]
     [Google Scholar]
  21. Kurt-Jones E. A., Mandell L., Whitney C., Padgett A., Gosselin K., Newburger P. E., Finberg R. W. 2002; Role of Toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100:1860–1868[PubMed]
     [Google Scholar]
  22. Lebbink R. J., Lowe M., Chan T., Khine H., Wang X., McManus M. T. 2011; Polymerase II promoter strength determines efficacy of microRNA adapted shRNAs. PLoS ONE 6:e26213 [View Article][PubMed]
     [Google Scholar]
  23. Murphy J. A., Duerst R. J., Smith T. J., Morrison L. A. 2003; Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol 77:9337–9345 [View Article][PubMed]
     [Google Scholar]
  24. Ning S. 2011; Innate immune modulation in EBV infection. World J. Emergency Surg. Herpesviridae 2:1 [View Article][PubMed]
     [Google Scholar]
  25. Paludan S. R., Bowie A. G., Horan K. A., Fitzgerald K. A. 2013; Recognition of herpesviruses by the innate immune system. Nat Rev Immunol 13:614 [View Article][PubMed]
     [Google Scholar]
  26. Park R., El-Guindy A., Heston L., Lin S. F., Yu K. P., Nagy M., Borah S., Delecluse H. J., Steitz J., Miller G. 2014; Nuclear translocation and regulation of intranuclear distribution of cytoplasmic poly(A)-binding protein are distinct processes mediated by two Epstein Barr virus proteins. PLoS ONE 9:e92593 [View Article][PubMed]
     [Google Scholar]
  27. Pasieka T. J., Lu B., Crosby S. D., Wylie K. M., Morrison L. A., Alexander D. E., Menachery V. D., Leib D. A. 2008; Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state. J Virol 82:5527–5535 [View Article][PubMed]
     [Google Scholar]
  28. Quinn L. L., Zuo J., Abbott R. J. M., Shannon-Lowe C., Tierney R. J., Hislop A. D., Rowe M. 2014; Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle. PLoS Pathog 10:e1004322 [View Article][PubMed]
     [Google Scholar]
  29. Ressing M. E., Keating S. E., van Leeuwen D., Koppers-Lalic D., Pappworth I. Y., Wiertz E. J. H. J., Rowe M. 2005; Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection. J Immunol 174:6829–6838 [View Article][PubMed]
     [Google Scholar]
  30. Ressing M. E., Horst D., Griffin B. D., Tellam J., Zuo J., Khanna R., Rowe M., Wiertz E. J. H. J. 2008; Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products. Semin Cancer Biol 18:397–408 [View Article][PubMed]
     [Google Scholar]
  31. Rickinson A. B., Kieff E. 2007; Epstein-Barr virus. In Field's Virology, 5th edn pp. 2655–2700 Edited by Knipe D. M., Howley P. M. Philadelphia: Lippincott Williams & Wilkins;
     [Google Scholar]
  32. Rowe M., Glaunsinger B., van Leeuwen D., Zuo J., Sweetman D., Ganem D., Middeldorp J., Wiertz E. J., Ressing M. E. 2007; Host shutoff during productive Epstein–Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci U S A 104:3366–3371 [View Article][PubMed]
     [Google Scholar]
  33. Sheridan V., Polychronopoulos L., Dutia B. M., Ebrahimi B. 2014; A shutoff and exonuclease mutant of murine gammaherpesvirus-68 yields infectious virus and causes RNA loss in type I interferon receptor knockout cells. J Gen Virol 95:1135–1143 [View Article][PubMed]
     [Google Scholar]
  34. van Gent M., Griffin B. D., Berkhoff E. G., van Leeuwen D., Boer I. G. J., Buisson M., Hartgers F. C., Burmeister W. P., Wiertz E. J., Ressing M. E. 2011; EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. J Immunol 186:1694–1702 [View Article][PubMed]
     [Google Scholar]
  35. van Gent M., Braem S. G. E., de Jong A., Delagic N., Peeters J. G. C., Boer I. G. J., Moynagh P. N., Kremmer E., Wiertz E. J.other authors 2014; Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with Toll-like receptor signaling. PLoS Pathog 10:e1003960 [View Article][PubMed]
     [Google Scholar]
  36. York I. A., Roop C., Andrews D. W., Riddell S. R., Graham F. L., Johnson D. C. 1994; A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77:525–535 [View Article][PubMed]
     [Google Scholar]
  37. Zuo J., Thomas W., van Leeuwen D., Middeldorp J. M., Wiertz E. J. H. J., Ressing M. E., Rowe M. 2008; The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function. J Virol 82:2385–2393 [View Article][PubMed]
     [Google Scholar]
  38. Zuo J., Currin A., Griffin B. D., Shannon-Lowe C., Thomas W. A., Ressing M. E., Wiertz E. J. H. J., Rowe M. 2009; The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog 5:e1000255 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000021
Loading
Silencing the shutoff protein of Epstein–Barr virus in productively infected B cells points to (innate) targets for immune evasion
J. Gen. Virol. 96, 858 (2015); https://doi.org/10.1099/jgv.0.000021
/content/journal/jgv/10.1099/jgv.0.000021
/content/journal/jgv/10.1099/jgv.0.000021
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error